HOME › DRUGS › TRALOKINUMAB
ACTIVE SUBSTANCE / INN

TRALOKINUMAB

Brand name(s): Adtralza, ADBRY
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
BLA761180
Dermatitis, Atopic
ACTIVE SUBSTANCE
Tralokinumab
REGULATORS
FDA · EMA
SPONSORS / MAH
LEO Pharma A/S, LEO PHARMA AS
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ADBRYBLA761180LEO PHARMA ASPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
AdtralzaLEO Pharma A/SAuthorised17/06/2021Dermatitis, Atopic

FULL INTELLIGENCE ON TRALOKINUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →